gazetteherald.co.uk
Yorkshire AI platform aiming to transform drug development named finalist
ConsoneAI, a Wetherby‑based AI firm, has been named a finalist in the Royal Society of Chemistry’s 2026 Emerging Technologies Competition for its drug‑development platform, DioScor. The system predicts drug efficacy and side‑effects across genders, ethnicities, and age groups in 90 seconds, using AI to model human and animal responses while accounting for genetic and demographic variables. Founder Mo Kosar highlighted the platform’s potential to shorten drug approval timelines and reduce bias in clinical trials. DioScor also offers a [...]